Submitted by Anonymous (not verified) on 18 September 2023 - 11:01
Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Hemophilia B, Date of authorisation: 11/05/2016, Revision: 12, Status: Authorised
Source: